Faculty

Institution

Unit

Venue

Oliver Brooks

Charles R. Drew University of Medicine and Science

Affiliations

Center Of Collaborative Alcohol Research

College of Medicine

Department Of Internal Medicine

Division Of Endocrinology, Metabolism, And Molecular Medicine

Oliver Brooks is a Senior Professor at Charles R. Drew University of Medicine and Science. His research focuses on vaccination policy, immunization practices, and public health epidemiology, with particular emphasis on COVID-19 and pediatric infectious diseases. His recent work examines the evolving role of the Advisory Committee on Immunization Practices (ACIP) in shaping US vaccine policy, including recommendations for COVID-19 boosters in immunocompromised populations and the use of Clesrovimab for preventing severe respiratory syncytial virus infections in infants. His publications have appeared in JAMA, Clinical Infectious Diseases, and MMWR.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Oliver Brooks

Charles R. Drew University of Medicine and Science

You can click a keyword to filter the displayed items

vaccination vaccines public health united states mortality covid-19 immunization practices advisory committee pediatrics epidemiology immunology respiratory medicine preventive medicine communicable diseases vaccine efficacy infection control vaccine development interim recommendations geriatrics infectious diseases (medical specialty) public health preparedness vaccine hesitancy interim recommendation clinical epidemiology veterinary medicine pediatric pulmonology hospital infections medical virology internal medicine health planning public health ethics covid-19 pandemic infectious respiratory disease pediatric lung diseases respiratory infections vaccine safety young children booster doses bivalent booster doses updated interim recommendations extended intervals primary series doses severe immunocompromise adult immunization schedule vaccine policy

Notable Scholarly Works

Notable Federal Grants

Collaborators

The Erosion of a Pillar of Public Health: Acip's Role and the Future of Us Vaccine Policy Post-June 2025. Clinical Infectious Diseases (2026)

vaccinationvaccinespreventive healthcarevaccine hesitancyhealth policypublic health ethicsvaccine efficacypreventive medicinepublic healthpolicy analysishealth planning

Advisory Committee on Immunization Practices at a Crossroads. JAMA (2025)

vaccinationvaccinesvaccine developmentcommunicable diseasesinfection controlinfectious diseasesinfectious diseases (medical specialty)immunologyimmunity (medicine)advisory committeepreventive medicinevaccine safety

The Path Forward for Vaccine Policy in the United States. UNC Libraries (2025)

vaccinationvaccinesvaccine hesitancyhealth policyvaccine policypreventive medicinepublic healthpublic health preparednessvaccine efficacy

Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus–Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2025. MMWR Morbidity and Mortality Weekly Report (2025)

vaccinationvaccinesmedicinepediatric pulmonologycommunicable diseasesinfectious diseasespediatricsmedical virologyhospital infectionsrespiratory infectionsinfectious diseases (medical specialty)pediatric lung diseasesinfectious respiratory disease

Use of Additional Doses of 2024–2025 Covid-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months With Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024. MMWR Morbidity and Mortality Weekly Report (2024)

Lauren E. RoperMonica GodfreyRuth Link-GellesDanielle L. MouliaChristopher A. TaylorGeorgina PeacockNoel BrewerOliver BrooksGeorge KuchelH. Keipp TalbotRobert SchechterKatherine E. Fleming-DutraLakshmi Panagiotakopoulos

vaccinationcovid-19vaccinesvaccine developmentimmunization practicesunited statessars-cov-2severe immunocompromiseimmunologypublic healthmortality

Use of an Additional Updated 2023–2024 Covid-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024. MMWR Morbidity and Mortality Weekly Report (2024)

vaccinationcovid-19vaccinescommunicable diseasesinfectious diseasespreventive medicinepublic health preparednessepidemiologyvaccine efficacy

Use of Covid-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–2025. MMWR Morbidity and Mortality Weekly Report (2024)

vaccinationcovid-19vaccinescommunicable diseasesinfection controlcovid-19 pandemicinfectious diseasespreventive medicineepidemiology

Recommended Adult Immunization Schedule, United States, 2023. Annals of Internal Medicine (2023)

Neil MurthyA. Patricia WodiSybil CineasKevin A. AultGrace M. LeeMelinda WhartonLynn BahtaBeth P. BellOliver BrooksWilbur H. ChenSybil CineasMatthew F. DaleyCamille Nelson KottonJamie LoehrSarah S. LongVeronica V. McNallyKatherine A. PoehlingPablo J. SánchezNirav D. ShahHelen Keipp TalbotKevin A. AultVeronica McNallyJohn EplingSarah ColesKatherine DebiecRhoda SperlingHolly FontenotAmy MiddlemanSandra FryhoferSarah McQueenMarie-Michele LegerMary-Margaret FillChad RittleWilliam SchafnerKen SchmaderPatsy StinchfieldMarci DreesPia PannarajDavid KimJane KimSusan FarrallUzo ChukwumaHank BernsteinPaul HunterPeter SzilagyiDiane PetersonCarolyn BridgesKaren KetnerKathleen HarrimanLitjen TanRobert HopkinsSusan LettA. Patricia WodiNeil Murthy

adult immunization scheduleinternal medicineunited stateshealth policypublic healthepidemiology

Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morbidity and Mortality Weekly Report (2023)

vaccinationvaccinescommunicable diseasesinfection controlpreventive medicinepublic healthepidemiologyvaccine efficacy

Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morbidity and Mortality Weekly Report (2023)

Jefferson M. JonesKatherine E. Fleming-DutraMila M. PrillLauren E. RoperOliver BrooksPablo J. SánchezCamille N. KottonBarbara E. MahonSarah MeyerSarah S. LongMeredith L. McMorrow

vaccinationyoung childrenimmunization practicesclinical epidemiologypediatricsunited statesimmunologyadvisory committeerespiratory medicinepublic healthmortality

1
2
10 / page

Oliver Brooks

Charles R. Drew University of Medicine and Science

Affiliations

Center Of Collaborative Alcohol Research

College of Medicine

Department Of Internal Medicine

Division Of Endocrinology, Metabolism, And Molecular Medicine

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Oliver Brooks

Charles R. Drew University of Medicine and Science

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

The Erosion of a Pillar of Public Health: Acip's Role and the Future of Us Vaccine Policy Post-June 2025. Clinical Infectious Diseases (2026)

vaccinationvaccinespreventive healthcarevaccine hesitancyhealth policypublic health ethicsvaccine efficacypreventive medicinepublic healthpolicy analysishealth planning

Advisory Committee on Immunization Practices at a Crossroads. JAMA (2025)

The Path Forward for Vaccine Policy in the United States. UNC Libraries (2025)

vaccinationvaccinesvaccine hesitancyhealth policyvaccine policypreventive medicinepublic healthpublic health preparednessvaccine efficacy

vaccinationcovid-19vaccinesvaccine developmentimmunization practicesunited statessars-cov-2severe immunocompromiseimmunologypublic healthmortality

vaccinationcovid-19vaccinescommunicable diseasesinfectious diseasespreventive medicinepublic health preparednessepidemiologyvaccine efficacy

vaccinationcovid-19vaccinescommunicable diseasesinfection controlcovid-19 pandemicinfectious diseasespreventive medicineepidemiology

Recommended Adult Immunization Schedule, United States, 2023. Annals of Internal Medicine (2023)

adult immunization scheduleinternal medicineunited stateshealth policypublic healthepidemiology

vaccinationvaccinescommunicable diseasesinfection controlpreventive medicinepublic healthepidemiologyvaccine efficacy

Jefferson M. JonesKatherine E. Fleming-DutraMila M. PrillLauren E. RoperOliver BrooksPablo J. SánchezCamille N. KottonBarbara E. MahonSarah MeyerSarah S. LongMeredith L. McMorrow

vaccinationyoung childrenimmunization practicesclinical epidemiologypediatricsunited statesimmunologyadvisory committeerespiratory medicinepublic healthmortality

1
2
10 / page